WallStreetZenWallStreetZen

NASDAQ: CAMP
Camp4 Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Camp4 Therapeutics revenue was N/A for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $858.0k, up 31.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CAMP annual revenue was $652.0k, with 86.3% growth year-over-year.

CAMP revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when CAMP announces revenue.

CAMP Revenue History By Year

CAMP Yearly RevenueCAMP RevenueCAMP ChangeCAMP Revenue Growth
2024-12-31$652.00k$302.00k+86.29%
2023-12-31$350.00kN/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Camp4 Therapeutics Revenue FAQ

What was CAMP's revenue last quarter?

Camp4 Therapeutics (NASDAQ: CAMP) reported Q1 2025 revenue of $858.00 thousand up Infinity% year over year. In the same quarter last year, Camp4 Therapeutics's revenue was $0.00.

What was Camp4 Therapeutics's revenue in 2024?

Camp4 Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $652.00 thousand, a 86.29% increase year over year.

How much does Camp4 Therapeutics make in a day?

Based on Camp4 Therapeutics annual revenue for the past two years, CAMP makes an average of $1,372.60 per day.

What was Camp4 Therapeutics's annual revenue growth in the past year?

As of Q3 2025, Camp4 Therapeutics's revenue has grown null year over year. Camp4 Therapeutics's revenue in the past year totaled N/A.

How much does Camp4 Therapeutics make in a year?

Camp4 Therapeutics's revenue by year for the past two years is:
  • Camp4 Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $652.00 thousand, a 86.29% increase year over year.
  • Camp4 Therapeutics's annual revenue for Dec 31, 2023 was $350.00 thousand, a Infinity% increase from 2022.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.